Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 11%
Buy 56%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Hldgs is a strong performer in the home healthcare industry, with a diverse payor mix, strong financial track record, and a recent successful acquisition. Although facing potential risks such as legislative rate initiatives and labor difficulties, Aveanna's focus on preferred payor relationships and potential for growth through M&A make it a positive investment option, outlined in its upgraded rating and target price of $10.

Bears say

Aveanna Healthcare Hldgs is facing numerous challenges, including labor shortages, reimbursement pressures from government payors, and regulatory risks. The company's reliance on government reimbursement for its private duty services segment and home health and hospice segment exposes it to potential changes in reimbursement policies. Its medical solutions segment's preferred payor strategy and cross-sell opportunities may help mitigate these risks, but there is still uncertainty surrounding the company's growth potential. Additionally, there are risks related to potential M&A execution and integration, as well as potential prolonged pandemic-related headwinds. The company's recent deleveraging and positive free cash flow generation are encouraging, but these alone may not be enough to overcome the potential risks and challenges Aveanna faces.

AVAH has been analyzed by 9 analysts, with a consensus rating of Buy. 11% of analysts recommend a Strong Buy, 56% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 9 analysts, AVAH has a Buy consensus rating as of Jun 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.